Ultragenyx Announces Proposed Public Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Ultragenyx Pharma (RARE) Prics 2.2M Common Stock Offering at $120/Share
July 16, 2015 6:43 AM EDTUltragenyx Pharma (Nasdaq: RARE) announced the pricing of its underwritten public offering of 2,200,000 shares of its common stock at a price to the public of $120 per share, before underwriting discounts. In addition, the company has granted the underwriters of the offering an option for a period of 30 days to purchase... More
Ultragenyx Pharma (RARE) Announces $250M Common Stock Offering
July 14, 2015 4:03 PM EDTUltragenyx Pharma (NASDAQ: RARE) announced that it has commenced an underwritten public offering of up to $250,000,000 of shares of its common stock. In addition, the company is expected to grant the underwriters of the offering an option for a period of 30 days to purchase up to an additional $37,500,000 of... More
